Medical therapeutics derived from leeches (Phy. Annelida; Cl. Hirudinea)

dc.contributor.author	Clarke, Christopher Everett Warren
dc.date.accessioned	2017-08-16
dc.date.accessioned	2022-05-28T00:37:49Z
dc.date.available	2022-05-28T00:37:49Z
dc.date.issued	2016
dc.description.abstract	Of all blood feeding invertebrates, few are more notorious than leeches. Throughout their existence as ectoparasites, leeches have evolved to release biological molecules in their saliva that act to counter the responses of the prey’s body to vascular trauma. Inadvertently, these very molecules have been used by humans for centuries for medicinal purposes; however, it is only recently that their cellular action has been elucidated. As a result, these compounds have been isolated and mass produced to treat a wide variety of conditions ranging from heart attack to Alzheimer’s disease and continued work suggests that these isolates will be an important future treatment for metastasis.
dc.format.extent	298.95 KB
dc.format.mimetype	PDF
dc.identifier.citation	Clarke, C. (2016). Medical therapeutics derived from leeches (Phy. Annelida; Cl. Hirudinea). MUSe, 3(1). Retrieved from https://journals.macewan.ca/muse/article/view/297
dc.identifier.uri	https://hdl.handle.net/20.500.14078/939
dc.language	English
dc.language.iso	en
dc.rights	All Rights Reserved
dc.subject	leeches
dc.subject	medicine
dc.title	Medical therapeutics derived from leeches (Phy. Annelida; Cl. Hirudinea)	en
dc.type	Student Article
dspace.entity.type

Files

Now showing 1 - 1 of 1